BY

BYLINE BANCORP, INC.
7 filings tracked
financialsasset managementSMALL ($300M-2B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

Byline Bancorp has successfully extended its revolving credit facility with CIBC Bank USA, securing a $15 million liquidity backstop through May 2027.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

The necessity of a third amendment to a relatively small credit facility raises questions about Byline Bancorp's ability to secure long-term, diversified funding.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every BY filing.

Start Free Trial

Synthesis (Verdict & Resolution)

Byline Bancorp's latest 8-K filing confirms the Third Amendment to its credit agreement with CIBC Bank USA, extending the $15 million revolving line of credit to May 23, 2027. While the extension ensures operational continuity and maintains a necessary liquidity buffer, the repetitive nature of these amendments highlights a dependency on a specific lending relationship. Investors must weigh the benefit of guaranteed short-term liquidity against the potential red flags of a restricted funding base.

Selected Quarter

Core Takeaway

Byline has pushed out its credit maturity by one year, maintaining a critical liquidity bridge but continuing a pattern of short-term renewals.

Investor Lens

Investors should monitor whether the bank can diversify its funding sources or if it remains tethered to a single lender via short-term extensions.

Watch Next

The next annual renewal cycle or any new capital raise filings to see if funding sources diversify.

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)+0.15Q2 '26 (8-K)

Signal Timeline

Active Filters:Quarter: Q2 '26 (8-K)
neutralMay 22

Extended maturity of a $15M revolving credit facility to May 2027.

debt restructure
40%
bullishMay 22

Maintained access to a critical liquidity line via lender agreement.

capital raise
30%
neutralMay 22

Extended maturity of a $15M revolving credit facility to May 2027.

debt restructure
40%
bullishMay 22

Maintained access to a critical liquidity line via lender agreement.

capital raise
30%
neutralMay 22

Extended maturity of a $15M revolving credit facility to May 2027.

debt restructure
40%
bullishMay 22

Maintained access to a critical liquidity line via lender agreement.

capital raise
30%
neutralMay 22

Extended maturity of a $15M revolving credit facility to May 2027.

debt restructure
40%
bullishMay 22

Maintained access to a critical liquidity line via lender agreement.

capital raise
30%
neutralMay 22

Extended maturity of a $15M revolving credit facility to May 2027.

debt restructure
40%
bullishMay 22

Maintained access to a critical liquidity line via lender agreement.

capital raise
30%
neutralMay 22

Extended maturity of a $15M revolving credit facility to May 2027.

debt restructure
40%
bullishMay 22

Maintained access to a critical liquidity line via lender agreement.

capital raise
30%
neutralMay 22

Extended maturity of a $15M revolving credit facility to May 2027.

debt restructure
40%
bullishMay 22

Maintained access to a critical liquidity line via lender agreement.

capital raise
30%

Filing History

8-KMay 22, 2026
Expand Sequence

Byline Bancorp's latest 8-K filing confirms the Third Amendment to its credit agreement with CIBC Bank USA, extending the $15 million revolving line of credit to May 23, 2027. While the extension ensures operational continuity and maintains a necessary liquidity buffer, the repetitive nature of these amendments highlights a dependency on a specific lending relationship. Investors must weigh the benefit of guaranteed short-term liquidity against the potential red flags of a restricted funding base.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.